Cargando…

A Quantitative ELISA Protocol for Detection of Specific Human IgG against the SARS-CoV-2 Spike Protein

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide pandemic with at least 3.8 million deaths to date. For that reason, finding an efficient vaccine for this virus quickly became a global priority. The majority of vaccines now marketed are based on the SARS-CoV-2 spik...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vernet, Rémi, Charrier, Emily, Grogg, Julien, Mach, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309958/ https://www.ncbi.nlm.nih.gov/pubmed/34358186 http://dx.doi.org/10.3390/vaccines9070770

Ejemplares similares

Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model
por: Vernet, Rémi, et al.
Publicado: (2021)

Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
por: Sapkal, Gajanan, et al.
Publicado: (2020)

A Quantitative ELISA to Detect Anti-SARS-CoV-2 Spike IgG Antibodies in Infected Patients and Vaccinated Individuals
por: Luo, Ji, et al.
Publicado: (2022)

Correlation between a quantitative anti‐SARS‐CoV‐2 IgG ELISA and neutralization activity
por: Dolscheid‐Pommerich, Ramona, et al.
Publicado: (2021)

Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva
por: Faustini, Sian E., et al.
Publicado: (2021)

Development and Optimization of In-house ELISA for Detection of Human IgG Antibody to SARS-CoV-2 Full Length Spike Protein
por: Alandijany, Thamir A., et al.
Publicado: (2020)

VLP-ELISA for the Detection of IgG Antibodies against Spike, Envelope, and Membrane Antigens of SARS-CoV-2 in Indian Population
por: Kumar, Dilip, et al.
Publicado: (2023)

Evaluation of Abbott anti-SARS-CoV-2 CMIA IgG and Euroimmun ELISA IgG/IgA assays in a clinical lab
por: Manalac, Justin, et al.
Publicado: (2020)

Validation of a Point‐of‐Care Quantitative Equine IgG Turbidimetric Immunoassay and Comparison of IgG Concentrations Measured with Radial Immunodiffusion and a Point‐of‐Care IgG ELISA
por: Ujvari, S., et al.
Publicado: (2017)

Impact of heat-inactivation on the detection of SARS-CoV-2 IgM and IgG antibody by ELISA
por: Hu, Xiumei, et al.
Publicado: (2020)

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations
por: Nyagwange, James, et al.
Publicado: (2022)

Comparison of the SARS-CoV-2 spike protein ELISA and the Abbott Architect SARS-CoV-2 IgG nucleocapsid protein assays for detection of antibodies
por: Wadhwa, Ashutosh, et al.
Publicado: (2021)

Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies
por: Beavis, Kathleen G., et al.
Publicado: (2020)

IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity
por: Wang, Jiong, et al.
Publicado: (2022)

Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
por: Yassine, Hadi M., et al.
Publicado: (2021)

Comparison of in-house IgM and IgG ELISAs for the serodiagnosis of melioidosis in Malaysia
por: Hii, Shirley Yi Fen, et al.
Publicado: (2017)

IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19
por: Wang, Gang, et al.
Publicado: (2022)

Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test
por: Kulkarni, Ruta, et al.
Publicado: (2021)

Anti-SARS-CoV-2 spike IgG antibodies prevalence: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Quantitative anti-PA IgG ELISA; assessment and comparability with the anthrax toxin neutralization assay in goats
por: Ndumnego, Okechukwu C, et al.
Publicado: (2013)

Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients
por: Van Elslande, J., et al.
Publicado: (2020)

Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding—Who Is Binding Who and Why?
por: Iles, Jason K., et al.
Publicado: (2022)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda
por: Oluka, Gerald Kevin, et al.
Publicado: (2023)

A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG
por: Zarletti, Gianpaolo, et al.
Publicado: (2020)

Side-By-Side Evaluation of Three Commercial ELISAs for the Quantification of SARS-CoV-2 IgG Antibodies
por: Girl, Philipp, et al.
Publicado: (2022)

Analytical Performance of the RIDASCREEN(®) Hantavirus Puumala IgG/IgM ELISA Assay
por: Depypere, Melissa, et al.
Publicado: (2020)

Standardization of in-house anti-IgG and IgA ELISAs for the detection of COVID-19
por: Rungrojcharoenkit, Kamonthip, et al.
Publicado: (2023)

IgG Avidity ELISA Test for Diagnosis of Acute Toxoplasmosis in Humans
por: Rahbari, Amir Hossien, et al.
Publicado: (2012)

Development and Application of an ELISA for the Detection of Porcine Deltacoronavirus IgG Antibodies
por: Thachil, Anil, et al.
Publicado: (2015)

Diagnosis of Ocular Toxocariasis by Serum and Aqueous Humor IgG ELISA
por: Huang, Li, et al.
Publicado: (2021)

Development of a Nucleocapsid Protein-Based ELISA for Detection of Human IgM and IgG Antibodies to SARS-CoV-2
por: Liu, Pan-pan, et al.
Publicado: (2021)

Performance of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies in South Africa
por: Gededzha, Maemu P., et al.
Publicado: (2021)

Development of a cost-effective quantitative in-house ELISA assay for screening anti-S1 IgG antibodies targeting SARS-CoV-2
por: AL-Saeedi, Abdul-Sattar, et al.
Publicado: (2023)

Significance of IgG optical density ratios (index value) in single reactive anti-Dengue virus IgG capture ELISA
por: Chatterjee, Shiv Sekhar, et al.
Publicado: (2016)

Limited specificity of commercially available SARS‐CoV‐2 IgG ELISAs in serum samples of African origin
por: Emmerich, Petra, et al.
Publicado: (2021)

Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein
por: Rodríguez, María Celeste, et al.
Publicado: (2022)

Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer
por: Kurt, Melike, et al.
Publicado: (2021)

Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer
por: Schwedler, Christian, et al.
Publicado: (2022)

Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples
por: Ibrahim, Essam H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p9sq7ofdjvfmqe1umen6moe186